Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: LncRNA RP3-525N10.2-NFKB1-PROS1 triplet-mediated low PROS1 expression is an onco-immunological biomarker in low-grade gliomas: a pan-cancer analysis with experimental verification

Fig. 4

The DNA methylation and Alternative Splicing (AS) of PROS1 in LGG. A The visualization between the DNA methylation level and PROS1 expression. B–D The Kaplan–Meier survival of the 3 promote (cg14753809, cg05897638, and cg24305970) methylation of PROS1. E–J Two Alternate promoters (PROS1_AP_65674 and PROS1_AP_65675) were found in TCGA SpliceSeq database that related with poor prognosis

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us